Cutia Therapeutics (HKG:2487)
Hong Kong · Delayed Price · Currency is HKD
4.700
+0.330 (7.55%)
At close: Mar 6, 2026
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
Developing Innovative and Comprehensive Solutions | 279.62M | 137.62M | 11.37M | 2.04M |
Developing Innovative and Comprehensive Solutions Growth | 103.17% | 1110.83% | 457.70% | - |
| 279.62M | 137.62M | 11.37M | 2.04M |
| 103.17% | 1110.83% | 457.70% | - |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
People’s Republic of China (PRC) | 279.62M | 137.62M | 11.37M | 2.04M |
People’s Republic of China (PRC) Growth | 103.17% | 1110.83% | 457.70% | - |
| 279.62M | 137.62M | 11.37M | 2.04M |
| 103.17% | 1110.83% | 457.70% | - |
Source: S&P Global Market Intelligence.
